Fatty liver disease: Should you be tested?
Weight-loss drug may lower risk of heart attacks and infections
Testosterone therapy without evidence of deficiency may boost heart risk
Even a little exercise linked with lower stroke risk in people with afib
Antihistamines may not offer meaningful relief from eczema symptoms
What to eat on the DASH diet
Tricep workouts you can do at home
FDA approves first mRNA-based flu vaccine
Migraine: How it's diagnosed and what that means
Mindfulness practices to reduce stress and improve focus
Marc B. Garnick, MD
Editor in Chief, Harvard Medical School Annual Report on Prostate Diseases; Editorial Advisory Board Member, Harvard Health Publishing
Dr. Marc B. Garnick is an internationally renowned expert in medical oncology and urologic cancer. A clinical professor of medicine at Harvard Medical School, he also maintains an active clinical practice at Beth Israel Deaconess Medical Center. He has dedicated his career to the development of new therapies for the treatment of prostate cancer.
Dr. Garnick is the Editor in Chief of HarvardProstateKnowledge.org and Harvard Medical School’s Annual Report on Prostate Diseases, both of which emerged from his keen interest in explaining issues of medical importance to patients and their families to help them make appropriate treatment choices.
Fatty liver disease: Should you be tested?
Weight-loss drug may lower risk of heart attacks and infections
Testosterone therapy without evidence of deficiency may boost heart risk
Even a little exercise linked with lower stroke risk in people with afib
Antihistamines may not offer meaningful relief from eczema symptoms
What to eat on the DASH diet
Tricep workouts you can do at home
FDA approves first mRNA-based flu vaccine
Migraine: How it's diagnosed and what that means
Mindfulness practices to reduce stress and improve focus
